Literature DB >> 9024633

p53; from inductive signal to cellular effect.

R Hansen1, M Oren.   

Abstract

During the past year, the story of how p53 suppresses carcinogenesis has increased in complexity. Further insight has been provided into the activation of latent p53, the biochemical mechanisms involved in growth arrest and apoptosis, and the influence of various signals on these cellular effects. Additionally, roles for p53 have been described in cell senescence, in suppressing teratogenesis, and in processes that may directly contribute to the maintenance of genomic stability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024633     DOI: 10.1016/s0959-437x(97)80108-6

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  40 in total

1.  Change of the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53.

Authors:  A Seluanov; V Gorbunova; A Falcovitz; A Sigal; M Milyavsky; I Zurer; G Shohat; N Goldfinger; V Rotter
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3' UTR of unusual length and structure.

Authors:  S Chen; S Y Le; D L Newton; J V Maizel; S M Rybak
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

3.  Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase alpha-primase.

Authors:  Christian Melle; Heinz-Peter Nasheuer
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

4.  Regulation of Cdc42-mediated morphological effects: a novel function for p53.

Authors:  Gilles Gadéa; Laure Lapasset; Cécile Gauthier-Rouvière; Pierre Roux
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

5.  DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation.

Authors:  Gang Liu; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

6.  Loss of nuclear p21(Cip1/WAF1) during neoplastic progression to metastasis in gamma-irradiated p21 hemizygous mice.

Authors:  Robert W Engelman; Rosalind J Jackson; Domenico Coppola; Walker Wharton; Alan B Cantor; W Jack Pledger
Journal:  Exp Mol Pathol       Date:  2007-01-04       Impact factor: 3.362

7.  Screening for novel binding proteins interacting with human papillomavirus type 18 E6 oncogene in the Hela cDNA library by yeast two-hybrid system.

Authors:  Shuang Li; Ping Liu; Ling Xi; Xuefeng Jiang; Jianfeng Zhou; Shixuan Wang; Li Meng; Yunping Lu; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

8.  Molecular basis of differentiation therapy for soft tissue sarcomas.

Authors:  Gaurav Luther; Richard Rames; Eric R Wagner; Gaohui Zhu; Qing Luo; Yang Bi; Stephanie H Kim; Jian-Li Gao; Enyi Huang; Ke Yang; Linyuan Wang; Xing Liu; Mi Li; Ning Hu; Yuxi Su; Xiaoji Luo; Liang Chen; Jinyong Luo; Rex C Haydon; Hue H Luu; Lan Zhou; Tong-Chuan He
Journal:  Trends Cancer Res       Date:  2010

9.  p53 regulates Hsp90beta during arsenite-induced cytotoxicity in glutathione-deficient cells.

Authors:  Geetha M Habib
Journal:  Arch Biochem Biophys       Date:  2008-10-26       Impact factor: 4.013

Review 10.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.